NASDAQ:INBS Intelligent Bio Solutions Q1 2027 Earnings Results & Report $2.25 -0.04 (-1.70%) As of 02:13 PM Eastern This is a fair market value price provided by Massive. Learn more. Intelligent Bio Solutions beat analyst earnings expectations in its Q1 2027 results, released November 10, 2026. The company reported EPS of -$0.86 versus the -$1.31 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateNovember 10, 2026TimeBefore Market OpensConference Call7:00 AM ET Intelligent Bio Solutions EPS ResultsActual EPS-$0.86Consensus EPS -$1.31Beat/MissBeat by +$0.45One Year Ago EPSN/AEPS Beat Rate2 of last 7 quartersIntelligent Bio Solutions Revenue ResultsActual RevenueN/AExpected Revenue$1.40 millionBeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsIntelligent Bio Solutions' Q2 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedulesConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Intelligent Bio Solutions Q1 2027 Earnings FAQ Did Intelligent Bio Solutions beat earnings estimates for Q1 2027? Intelligent Bio Solutions (NASDAQ:INBS) reported earnings of -$0.86 per share for Q1 2027, beating the consensus estimate of -$1.31. The report was announced on Tuesday, November 10, 2026. When is Intelligent Bio Solutions' next earnings date? Intelligent Bio Solutions' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Intelligent Bio Solutions on the company's earnings history page. Intelligent Bio Solutions Earnings HeadlinesIntelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year GrowthNovember 10 at 8:30 AM | globenewswire.comIntelligent Bio Solutions (INBS) Set to Announce Earnings on WednesdayNovember 10 at 2:57 AM | americanbankingnews.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 10 at 1:00 AM | Porter & Company (Ad)Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12November 4, 2026 | globenewswire.comIntelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System TranscriptSeptember 24, 2026 | seekingalpha.comIntelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ETSeptember 10, 2026 | globenewswire.comSee More Intelligent Bio Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email. Email Address About Intelligent Bio SolutionsIntelligent Bio Solutions (NASDAQ:INBS) (NASDAQ: INBS) is a life sciences company focused on developing and commercializing non-invasive diagnostic and screening technologies. Its primary product is the Intelligent Bio Solutions Drug Screening System, a portable platform designed to detect drugs of abuse through sweat collected from a person’s fingerprint. The system uses a disposable drug screening cartridge and a handheld reader to analyze fingerprint sweat and provide results rapidly. The company markets the technology for applications such as workplace testing, law enforcement, rehabilitation programs, and other settings that require convenient, observed drug screening. Intelligent Bio Solutions was formerly known as GBS Inc. and adopted its current name following its acquisition and integration of Intelligent Fingerprinting, a United Kingdom-based developer of fingerprint-based drug screening technology. The company serves customers in international markets, including the United Kingdom, Australia, and other regions where its products have received applicable regulatory or commercial clearances. Harry Simeonidis serves as president and chief executive officer.View Intelligent Bio Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
